Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells

Authors: Ai-Yu Gong, Alex N Eischeid, Jing Xiao, Jian Zhao, Dongqing Chen, Zhao-Yi Wang, Charles YF Young, Xian-Ming Chen

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Androgen receptor (AR) signalling is critical to the initiation and progression of prostate cancer (PCa). Transcriptional activity of AR involves chromatin recruitment of co-activators, including the p300/CBP-associated factor (PCAF). Distinct miRNA expression profiles have been identified in PCa cells during the development and progression of the disease. Whether miRNAs regulate PCAF expression in PCa cells to regulate AR transcriptional activity is still unclear.

Methods

Expression of PCAF was investigated in several PCa cell lines by qRT-PCR, Western blot, and immunocytochemistry. The effects of PCAF expression on AR-regulated transcriptional activity and cell growth in PCa cells were determined by chromatin immunoprecipitation, reporter gene construct analysis, and MTS assay. Targeting of PCAF by miR-17-5p was evaluated using the luciferase reporter assay.

Results

PCAF was upregulated in several PCa cell lines. Upregulation of PCAF promoted AR transcriptional activation and cell growth in cultured PCa cells. Expression of PCAF in PCa cells was associated with the downregulation of miR-17-5p. Targeting of the 3’-untranslated region of PCAF mRNA by miR-17-5p caused translational suppression and RNA degradation, and, consequently, modulation of AR transcriptional activity in PCa cells.

Conclusions

PCAF is upregulated in cultured PCa cells, and upregulation of PCAF is associated with the downregulation of miR-17-5p. Targeting of PCAF by miR-17-5p modulates AR transcriptional activity and cell growth in cultured PCa cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.CrossRefPubMed
2.
go back to reference Culig Z, Bartsch G: Androgen axis in prostate cancer. J Cell Biochem. 2006, 99: 373-381. 10.1002/jcb.20898.CrossRefPubMed Culig Z, Bartsch G: Androgen axis in prostate cancer. J Cell Biochem. 2006, 99: 373-381. 10.1002/jcb.20898.CrossRefPubMed
3.
4.
go back to reference Debes JD, Tindall DJ: Mechanisms of androgen-refractory prostate cancer. N Engl J Med. 2004, 351: 1488-1490. 10.1056/NEJMp048178.CrossRefPubMed Debes JD, Tindall DJ: Mechanisms of androgen-refractory prostate cancer. N Engl J Med. 2004, 351: 1488-1490. 10.1056/NEJMp048178.CrossRefPubMed
5.
6.
go back to reference Nagy ZL, Tora L: Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene. 2007, 26: 5341-5357. 10.1038/sj.onc.1210604.CrossRefPubMed Nagy ZL, Tora L: Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene. 2007, 26: 5341-5357. 10.1038/sj.onc.1210604.CrossRefPubMed
7.
go back to reference Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM: Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer. 2007, 120: 719-733. 10.1002/ijc.22365.CrossRefPubMed Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM: Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer. 2007, 120: 719-733. 10.1002/ijc.22365.CrossRefPubMed
8.
go back to reference Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5.CrossRefPubMed Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5.CrossRefPubMed
9.
go back to reference Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genetics. 2010, 11: 597-610.PubMed Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genetics. 2010, 11: 597-610.PubMed
11.
go back to reference Iorio MV, Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012, 4: 143-159. 10.1002/emmm.201100209.CrossRefPubMedPubMedCentral Iorio MV, Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012, 4: 143-159. 10.1002/emmm.201100209.CrossRefPubMedPubMedCentral
12.
go back to reference Kasinski AL, Slack FJ: MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011, 11: 849-864. 10.1038/nrc3166.CrossRefPubMedPubMedCentral Kasinski AL, Slack FJ: MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011, 11: 849-864. 10.1038/nrc3166.CrossRefPubMedPubMedCentral
13.
go back to reference Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A: The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets. 2012, 16: S103-S109.CrossRefPubMed Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A: The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets. 2012, 16: S103-S109.CrossRefPubMed
14.
go back to reference Sevli S, Uzumcu A, Solak M, Ittmann M, Ozen M: The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis. 2010, 13: 208-217. 10.1038/pcan.2010.21.CrossRefPubMed Sevli S, Uzumcu A, Solak M, Ittmann M, Ozen M: The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis. 2010, 13: 208-217. 10.1038/pcan.2010.21.CrossRefPubMed
15.
go back to reference Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011, 17: 211-215. 10.1038/nm.2284.CrossRefPubMedPubMedCentral Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011, 17: 211-215. 10.1038/nm.2284.CrossRefPubMedPubMedCentral
16.
go back to reference Maugeri-Saccà M, Coppola V, Bonci D, De Maria R: MicroRNAs and prostate cancer: from preclinical research to translational oncology. Cancer J. 2012, 18: 253-261. 10.1097/PPO.0b013e318258b5b6.CrossRefPubMed Maugeri-Saccà M, Coppola V, Bonci D, De Maria R: MicroRNAs and prostate cancer: from preclinical research to translational oncology. Cancer J. 2012, 18: 253-261. 10.1097/PPO.0b013e318258b5b6.CrossRefPubMed
17.
go back to reference Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007, 315: 1579-1582. 10.1126/science.1136319.CrossRefPubMed Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007, 315: 1579-1582. 10.1126/science.1136319.CrossRefPubMed
18.
go back to reference Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006, 103: 2257-2261. 10.1073/pnas.0510565103.CrossRefPubMedPubMedCentral Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006, 103: 2257-2261. 10.1073/pnas.0510565103.CrossRefPubMedPubMedCentral
19.
go back to reference Sikand K, Slane SD, Shukla GC: Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int. 2009, 9: 21-10.1186/1475-2867-9-21.CrossRefPubMedPubMedCentral Sikand K, Slane SD, Shukla GC: Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int. 2009, 9: 21-10.1186/1475-2867-9-21.CrossRefPubMedPubMedCentral
20.
go back to reference Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE: MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis. 2009, 26: 965-979. 10.1007/s10585-009-9287-2.CrossRefPubMed Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE: MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis. 2009, 26: 965-979. 10.1007/s10585-009-9287-2.CrossRefPubMed
21.
go back to reference Gong AY, Hu G, Zhou R, Liu J, Feng Y, Soukup GA, Chen XM: MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int J Parasitol. 2011, 41: 397-403. 10.1016/j.ijpara.2010.11.011.CrossRefPubMedPubMedCentral Gong AY, Hu G, Zhou R, Liu J, Feng Y, Soukup GA, Chen XM: MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int J Parasitol. 2011, 41: 397-403. 10.1016/j.ijpara.2010.11.011.CrossRefPubMedPubMedCentral
22.
go back to reference Gong AY, Zhou R, Hu G, Liu J, Sosnowska D, Drescher KM, Dong H, Chen XM: Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating microRNA-513. J Infect Dis. 2010, 201: 160-169. 10.1086/648589.CrossRefPubMedPubMedCentral Gong AY, Zhou R, Hu G, Liu J, Sosnowska D, Drescher KM, Dong H, Chen XM: Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating microRNA-513. J Infect Dis. 2010, 201: 160-169. 10.1086/648589.CrossRefPubMedPubMedCentral
23.
go back to reference Gaughan L, Logan IR, Neal DE, Robson CN: Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005, 33: 13-26. 10.1093/nar/gki141.CrossRefPubMedPubMedCentral Gaughan L, Logan IR, Neal DE, Robson CN: Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005, 33: 13-26. 10.1093/nar/gki141.CrossRefPubMedPubMedCentral
24.
go back to reference Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007, 449: 919-922. 10.1038/nature06205.CrossRefPubMedPubMedCentral Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007, 449: 919-922. 10.1038/nature06205.CrossRefPubMedPubMedCentral
25.
go back to reference Gong AY, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY: Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res. 2009, 53: 878-886. 10.1002/mnfr.200800253.CrossRefPubMedPubMedCentral Gong AY, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY: Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res. 2009, 53: 878-886. 10.1002/mnfr.200800253.CrossRefPubMedPubMedCentral
26.
go back to reference Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H: Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem. 2010, 339: 253-262. 10.1007/s11010-010-0388-7.CrossRefPubMed Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H: Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem. 2010, 339: 253-262. 10.1007/s11010-010-0388-7.CrossRefPubMed
27.
go back to reference Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S: TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res. 2008, 68: 3486-3494. 10.1158/0008-5472.CAN-07-6059.CrossRefPubMed Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S: TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res. 2008, 68: 3486-3494. 10.1158/0008-5472.CAN-07-6059.CrossRefPubMed
28.
go back to reference Fu M, Wang C, Reutens AT, Angelletti R, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG: p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem. 2000, 275: 20853-20860. 10.1074/jbc.M000660200.CrossRefPubMed Fu M, Wang C, Reutens AT, Angelletti R, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG: p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem. 2000, 275: 20853-20860. 10.1074/jbc.M000660200.CrossRefPubMed
29.
go back to reference Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Jänne OA, Palvimo JJ, Pestell RG: Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol. 2001, 15: 797-811. 10.1210/me.15.5.797.CrossRefPubMed Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Jänne OA, Palvimo JJ, Pestell RG: Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol. 2001, 15: 797-811. 10.1210/me.15.5.797.CrossRefPubMed
Metadata
Title
miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells
Authors
Ai-Yu Gong
Alex N Eischeid
Jing Xiao
Jian Zhao
Dongqing Chen
Zhao-Yi Wang
Charles YF Young
Xian-Ming Chen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-492

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine